1. Home
  2. NHS vs HRTX Comparison

NHS vs HRTX Comparison

Compare NHS & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NHS
  • HRTX
  • Stock Information
  • Founded
  • NHS 2003
  • HRTX 1983
  • Country
  • NHS United States
  • HRTX United States
  • Employees
  • NHS N/A
  • HRTX N/A
  • Industry
  • NHS Trusts Except Educational Religious and Charitable
  • HRTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NHS Finance
  • HRTX Health Care
  • Exchange
  • NHS Nasdaq
  • HRTX Nasdaq
  • Market Cap
  • NHS 226.7M
  • HRTX 214.5M
  • IPO Year
  • NHS N/A
  • HRTX 1987
  • Fundamental
  • Price
  • NHS $7.52
  • HRTX $1.16
  • Analyst Decision
  • NHS
  • HRTX Strong Buy
  • Analyst Count
  • NHS 0
  • HRTX 2
  • Target Price
  • NHS N/A
  • HRTX $4.50
  • AVG Volume (30 Days)
  • NHS 111.8K
  • HRTX 1.5M
  • Earning Date
  • NHS 01-01-0001
  • HRTX 11-04-2025
  • Dividend Yield
  • NHS 13.44%
  • HRTX N/A
  • EPS Growth
  • NHS N/A
  • HRTX N/A
  • EPS
  • NHS N/A
  • HRTX N/A
  • Revenue
  • NHS N/A
  • HRTX $149,694,000.00
  • Revenue This Year
  • NHS N/A
  • HRTX $10.62
  • Revenue Next Year
  • NHS N/A
  • HRTX $12.99
  • P/E Ratio
  • NHS N/A
  • HRTX N/A
  • Revenue Growth
  • NHS N/A
  • HRTX 9.78
  • 52 Week Low
  • NHS $6.95
  • HRTX $1.04
  • 52 Week High
  • NHS $9.17
  • HRTX $2.68
  • Technical
  • Relative Strength Index (RSI)
  • NHS 56.80
  • HRTX 38.28
  • Support Level
  • NHS $7.14
  • HRTX $1.16
  • Resistance Level
  • NHS $7.37
  • HRTX $1.21
  • Average True Range (ATR)
  • NHS 0.11
  • HRTX 0.07
  • MACD
  • NHS 0.03
  • HRTX -0.01
  • Stochastic Oscillator
  • NHS 86.56
  • HRTX 8.33

About NHS Neuberger Berman High Yield Strategies Fund

Neuberger Berman High Yield Strategies Fund Inc is a diversified, closed-end management investment company. The company invests in high yield debt securities market. The Fund uses leverage to pursue its investment objective. The Fund may invest in a variety of direct debt instruments, including bank loans, notes and other interests in amounts owed to financial institutions by borrowers, such as companies and governments. Corporate loans in which the Fund may invest will consist of direct obligations of borrowers. The Fund may invest in corporate loans at origination as a co-lender or may acquire loans in the secondary market by purchasing participations in, assignments of or novations of corporate loans.

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Share on Social Networks: